DexCom, Inc.
DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time APIā¦ read more
Healthcare
Medical Devices
21 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$83.45
Price+11.95%
$8.91
1Y
Price
Market Cap
$32.201b
Large
Price/Earnings 3y Avg5y Avg
35.8x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+29.7%
EBITDA Margin+19.0%
Net Profit Margin+14.1%
Free Cash Flow Margin+29.7%
EBITDA Margin+19.0%
Net Profit Margin+14.1%
Free Cash Flow MarginRevenue
$4.969b
+6.6%
1y CAGR+11.2%
3y CAGR+14.5%
5y CAGREarnings
$999.700m
+19.5%
1y CAGR+23.7%
3y CAGR+32.5%
5y CAGREPS
$2.53
+21.1%
1y CAGR+25.8%
3y CAGR+35.0%
5y CAGRBook Value
$2.621b
$6.455b
Assets$3.834b
Liabilities$1.346b
DebtDebt to Assets
20.9%
0.9x
Debt to EBITDAFree Cash Flow
$1.405b
+30.4%
1y CAGR+41.5%
3y CAGR+48.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company